Towards Healthcare Research & Consulting

News

Your Daily Gateway to Essential News in Healthcare, Science, Technology and Business Worldwide

OneLegacy Partners with OrganOx to Expand Liver Transplant Access
30 July 2026

OneLegacy Partners with OrganOx to Expand Liver Transplant Access

OneLegacy Partners with OrganOx to Transform Liver Transplantation, Offering Advanced Medical Solutions to Transplant Centers in Southern California OneLegacy is providing well-developed healthcare services to Southern California transplant centers via liver perfusion with the OrganOx metra. Normot...

Cepheid to Unveil Third-Generation GeneXpert System at ADLM 2026, Advancing Molecular Diagnostic Capabilities
28 July 2026

Cepheid to Unveil Third-Generation GeneXpert System at ADLM 2026, Advancing Molecular Diagnostic Capabilities

Cepheid, a Danaher organization, and a significant player in molecular diagnostics, unveil the third generation of the GeneXpert technology at the Association for Diagnostics & Laboratory Medicine (ADLM) Annual Scientific Meeting in a special booth presentation on Tuesday. The next-generation system...

DES Pharma Consulting and Adept Packaging Form Strategic Alliance to Accelerate Drug Development and Commercialization
28 July 2026

DES Pharma Consulting and Adept Packaging Form Strategic Alliance to Accelerate Drug Development and Commercialization

DES Pharma Consulting and Adept Packaging announced a strategic alliance, formalized in June 2026, to offer biotech and pharmaceutical organizations with an incorporated strategies to CMC approaches, quality systems, and pharmaceutical packaging in the product lifecycle. Packaging is considered as ...

Insmed Reports Positive 12-Month TPIP Data for Pulmonary Arterial Hypertension
24 July 2026

Insmed Reports Positive 12-Month TPIP Data for Pulmonary Arterial Hypertension

Insmed Moved Closer to $6B Opportunity as PAH Drug Shows Long-Term DurabilityInsmed's inhalable candidate presented "impressive" long-term effectiveness in pulmonary arterial hypertension, base on analysts at Guggenheim Partners, with functional and biomarker advancement via one year of follow-up. ...

Creative Diagnostics Launches Hantavirus Research Reagents and Products to Accelerate
28 July 2026

Creative Diagnostics Launches Hantavirus Research Reagents and Products to Accelerate

Creative Diagnostics, a significant producer and supplier of antigens, antibodies and assay kits, has announced its Hantavirus Research Reagents and Products to helps hantavirus study and diagnostic assay advancement. This inclusive catalog supports academic researchers, pharmaceutical organizations...

IPC and UPPPC Partner to Strengthen Medical Equipment Quality and Innovation
24 July 2026

IPC and UPPPC Partner to Strengthen Medical Equipment Quality and Innovation

The Indian Pharmacopoeia Commission (IPC) has partnered a Memorandum of Understanding (MoU) with the Uttar Pradesh Promote Pharma Council (UPPPC) to toughen quality standards, novelty and governing excellence in the healthcare and medical tool sectors. The MoU was signed while the YEIDA MedTech Inve...

Evonik Strengthens U.S. Pharmaceutical Manufacturing with New API Facility in Indiana
23 July 2026

Evonik Strengthens U.S. Pharmaceutical Manufacturing with New API Facility in Indiana

Major Investment Expands Manufacturing Capabilities Evonik has officially opened its newly upgraded active pharmaceutical ingredient (API) manufacturing facility in Lafayette, Indiana, marking an important step in strengthening pharmaceutical production in the U.S. The company is investing US$100 m...

FDA Warns BMC Medical Over Unauthorized CPAP Device Changes
23 July 2026

FDA Warns BMC Medical Over Unauthorized CPAP Device Changes

FDA Issues Warning After Inspection of CPAP Devices The U.S. Food and Drug Administration (FDA) has issued a warning letter to a China-based medical device manufacturer, BMC Medical, after identifying significant regulatory concerns related to its continuous positive airway pressure (CPAP) devices....

Nava Therapeutics Launches with $89M to Advance Extrahepatic LNP Delivery for In Vivo CAR-T and Kidney Gene Editing
24 July 2026

Nava Therapeutics Launches with $89M to Advance Extrahepatic LNP Delivery for In Vivo CAR-T and Kidney Gene Editing

Nava Therapeutics has launched with $89 million in funding to advance a lipid nanoparticle platform intended to deliver RNA medicines beyond the liver, with initial programs significantly focused on in vivo CAR-T and kidney-targeted genetic medication. The Cambridge and Philadelphia-based organizat...

FDA Writes to Infant Formula Manufacturers Urging Them to Tighten Supplier Oversight
21 July 2026

FDA Writes to Infant Formula Manufacturers Urging Them to Tighten Supplier Oversight

The US Food and Drug Administration (FDA) has advised infant formula producers to tighten supplier oversight after botulism outbursts and a contaminated ingredient triggered recalls in multiple markets. The regulator called on producers and supply chain collaboration to identify where ingredients o...